Clinical Trial Update: Gemigliptin, Dapagliflozin, Empagliflozin DDI Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating drug-drug interactions among gemigliptin, dapagliflozin, and empagliflozin in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)
• Gemigliptin (gemigliptin)

Snippet

Sponsor: LG Chem | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN